Castleview Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,113
Closed -$75.5K 567
2024
Q2
$75.5K Buy
+8,113
New +$75.5K 0.04% 267